Magtortor, Efren D.

HRN: 25-25-04  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2024
CEFTRIAXONE 1G (VIAL)
06/04/2024
06/11/2024
IV
2g
Q24
T/C Strangulated Indirect Inguinal Hernia R
Waiting Final Action 
06/04/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/04/2024
06/11/2024
IV
500mg
Q8
T/C Stranguated Indirect Inguina Hernia R
Waiting Final Action 
06/06/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/06/2024
06/13/2024
IVT
4.5 G
Q6H
S/P INGUINAL EXPLORATION
Waiting Final Action 
06/06/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/06/2024
06/13/2024
IVT
500 MG
Q8H
S/P INGUINAL EXPLORATION
Waiting Final Action 
06/09/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/09/2024
06/16/2024
IV
2.25gm
Q8H
S/P Exploratory Laparotomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: